Minimally Invasive Pharmacokinetic and Pharmacodynamic Technologies in Hypothesis-Testing Clinical Trials of Innovative Therapies
Year: 2006
Type: review
DOI: 10.1093/jnci/djj162
Institutions: Novartis (Switzerland), Royal Marsden NHS Foundation Trust, Institute of Cancer Research, St George's, University of London, Mount Vernon Hospital, Cancer Research UK, University of Manchester, Cancer Research UK Manchester Institute, Novartis Institutes for BioMedical Research, Imperial College London
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2169644362
